• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab.重症新型冠状病毒肺炎中的高流量鼻导管给氧与托珠单抗
Infect Dis Now. 2022 Aug;52(5):324-325. doi: 10.1016/j.idnow.2022.04.008. Epub 2022 May 7.
2
Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.托珠单抗治疗 COVID-19 诱导的细胞因子风暴和急性呼吸窘迫综合征：来自宾夕法尼亚州西部农村一级创伤中心的病例系列。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211019557. doi: 10.1177/23247096211019557.
3
Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital.皮质类固醇和托珠单抗可降低重症 COVID-19 肺炎患者的院内死亡率：一项西班牙医院的回顾性研究
Infect Dis (Lond). 2021 Apr;53(4):291-302. doi: 10.1080/23744235.2021.1884286. Epub 2021 Feb 23.
4
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.托珠单抗联合瑞德西韦治疗重症 COVID-19 肺炎住院患者：一项随机临床试验。
Intensive Care Med. 2021 Nov;47(11):1258-1270. doi: 10.1007/s00134-021-06507-x. Epub 2021 Oct 5.
5
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.托珠单抗与标准治疗对 COVID-19 肺炎住院患者临床恶化的影响：一项随机临床试验。
JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615.
6
Successful treatment of severe COVID-19 pneumonia with tocilizumab: A series of three cases.托珠单抗成功治疗重症 COVID-19 肺炎：三例系列报道。
Cardiol J. 2021;28(6):979-982. doi: 10.5603/CJ.a2021.0138. Epub 2021 Oct 28.
7
Tocilizumab challenge: A series of cytokine storm therapy experiences in hospitalized COVID-19 pneumonia patients.托珠单抗挑战：住院 COVID-19 肺炎患者细胞因子风暴治疗经验系列。
J Med Virol. 2020 Nov;92(11):2648-2656. doi: 10.1002/jmv.26111. Epub 2020 Jun 29.
8
Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia.测试托珠单抗对新冠肺炎肺炎患者的疗效。
J Comp Eff Res. 2021 Jun;10(8):625-627. doi: 10.2217/cer-2021-0050. Epub 2021 Apr 23.
9
Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab use.成功的高流量鼻导管治疗严重 COVID-19 肺炎与托珠单抗的使用相关。
Infect Dis Now. 2022 May;52(3):145-148. doi: 10.1016/j.idnow.2022.02.006. Epub 2022 Feb 14.
10
Tocilizumab Accelerates Recovery in Patients With Severe COVID-19 Pneumonia on Venovenous Extracorporeal Membrane Oxygenation.托珠单抗可加速接受静脉-静脉体外膜肺氧合治疗的重症新型冠状病毒肺炎患者的康复。
ASAIO J. 2022 Aug 1;68(8):1010-1016. doi: 10.1097/MAT.0000000000001707. Epub 2022 Apr 28.

本文引用的文献

1
Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab use.成功的高流量鼻导管治疗严重 COVID-19 肺炎与托珠单抗的使用相关。
Infect Dis Now. 2022 May;52(3):145-148. doi: 10.1016/j.idnow.2022.02.006. Epub 2022 Feb 14.
2
Validation of Respiratory Rate-Oxygenation Index in Patients With COVID-19-Related Respiratory Failure.新型冠状病毒肺炎相关呼吸衰竭患者呼吸频率-氧合指数的验证。
Crit Care Med. 2022 Jul 1;50(7):e638-e642. doi: 10.1097/CCM.0000000000005474. Epub 2022 Feb 7.
3
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study.COVID-19 肺炎患者使用头盔式 CPAP 失败的预测因素：一项前瞻性、多中心、观察性队列研究。
Can Respir J. 2022 Jan 21;2022:1499690. doi: 10.1155/2022/1499690. eCollection 2022.
4
Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia.比较ROX和HACOR量表预测新型冠状病毒肺炎患者高流量鼻导管吸氧失败的情况。
Sci Rep. 2021 Nov 19;11(1):22559. doi: 10.1038/s41598-021-02078-5.
5
When Conventional Oxygen Therapy Fails-The Effectiveness of High-Flow Nasal Oxygen Therapy in Patients with Respiratory Failure in the Course of COVID-19.当常规氧疗失败时——高流量鼻导管给氧疗法对新型冠状病毒肺炎（COVID-19）所致呼吸衰竭患者的疗效
J Clin Med. 2021 Oct 16;10(20):4751. doi: 10.3390/jcm10204751.
6
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia.确定托珠单抗在新冠病毒肺炎治疗中地位的随机试验系统评价和亚组荟萃分析
Infect Dis Ther. 2021 Sep;10(3):1195-1213. doi: 10.1007/s40121-021-00488-6. Epub 2021 Jul 11.
7
Tocilizumab in COVID-19 pneumonia: Practical proposals based on a narrative review of randomised trials.托珠单抗治疗 COVID-19 肺炎：基于随机对照试验的叙述性综述的实用建议。
Rev Med Virol. 2022 Jan;32(1):e2239. doi: 10.1002/rmv.2239. Epub 2021 Apr 21.

High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab.

作者信息

Mandal M, Mazza M, Esquinas A M

机构信息

Department of Anesthesiology, Institute of Post Graduate Medical Education & Research, 244, Acharya Jagadish Chandra Bose Road, Kolkata 700 020, India.

UOC Pneumologia Semintensiva COVID, A.O. Sant'Anna e San Sebastiano, di Rilievo Nazionale e alta Specializzazione, Via Ferdinando Palasciano, 81100 Caserta, Italy.

出版信息

Infect Dis Now. 2022 Aug;52(5):324-325. doi: 10.1016/j.idnow.2022.04.008. Epub 2022 May 7.

DOI:10.1016/j.idnow.2022.04.008
PMID:35537687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9077897/
Abstract
摘要